Materials
MORE INFORMATION ABOUT TRIMA ACCEL 7
Abstracts Featuring Trima Accel 7
Deveci B, Altunay H, Veske H, et al. Enhanced donor eligibility on Trima Accel version 7.0. Vox Sang. 2017;112(suppl 1):116.
Deveci B, Altunay H, Veske H, et al. Evaluation of Trima Accel version 7.0 autoflow. Vox Sang. 2017;112(suppl 1):117.
Lopert P, Rhodes J, Cancelas J, et al. A multicenter study to assess the performance of Trima Accel 7 for the collection of platelets stored in platelet additive solution. Transfusion. 2018;58(suppl 2):146A.
Lopert P, Carlin B, Irani MS, et al. Hyperconcentrated platelets collected on Trima Accel and stored in Intersol solution for 5 days meet FDA acceptance criteria for in vivo platelet recovery and survival. Transfusion. 2018;58(suppl 2):146A.
Lopert P, Aga G, Rice J, et al. Apheresis platelets collected on Trima Accel and stored in Intersol platelet additive solution for 5 and 7 days are comparable for pH and morphology to plasma-stored platelets in vitro. Transfusion. 2018;58(suppl 2):147A.
Argumanis ES, Ramirez MD, Gomez A, Alosilla L, Howell A, Simon-Blum L. A blood center experience—Trima Accel 7. Transfusion. 2018;58(suppl 2):148A.
Lopert P, Rhodes J, Cancelas J, et al. A multicenter study to assess the performance of Trima Accel 7 for the collection of platelets stored in 100% plasma. Transfusion. 2018;58(suppl 2):149A.
Rodriguez A, Forero S, Baquero D, et al. Evaluation of operational efficiencies with Trima Accel 7. Transfusion. 2018;58(suppl 2):151A.
Lopert P, Rhodes J, Fender L, et al. A multicenter study to evaluate the modified postcount algorithm on the Trima Accel system. Transfusion. 2018;58(suppl 2):151A.
*The Trima Accel system is available in select markets.
Actual results may vary by customer.
1Eder AF, Dy BA, DeMerse B, et al. Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions. Transfusion. 2017;57(12):2969-2976.
2Bravo M, Shaz BH, Kamel H, et al. Detection of bacterial contamination in apheresis platelets: is apheresis technology a factor? Transfusion. 2015;55(9):2113-2122.
3Tobian AAR, King KE, Borge PD, Fuller AK, Uglik K, Ness PM. Platelet corrected count increments by apheresis platform.Transfusion. 2016;56(10):2584-2586.